Liver Diseases
Breath biomarker discovery with Breath Biopsy® and EVOC® Probes could lead to non-invasive early detection and disease progression monitoring for NAFLD, NASH and other liver diseases.
Find Out More
Presentation: Developing EVOC Probes for liver disease
As part of BBCon21, Giuseppe Ferrandino presents our latest work developing exogenous VOC probes for high sensitivity, high contrast detection of liver disease using breath.
View Presentation
Review: Perspectives on breath for detection of liver disease
An overview of existing research into breath tests for chronic liver diseases, and preliminary results of our untargeted Breath Biopsy research.
View Review
Interview: Rob Smith, Senior Applications Chemist
Meet Rob Smith, Senior Applications Chemist at Owlstone Medical, working with the GC-MS technology to link levels of breath limonene with cirrhosis.
Read Now
Publication: Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound
View Publication
Partners
We’re working on liver disease with these groups:
 |
 |
 |
Getting started with Breath Biopsy
Transform your research workflow
Using Breath Biopsy to identify biomarkers of liver function
View our Webinar
Recommended Reading
Other recommended reading:
- POSTER: Comparing cirrhosis and liver cancers – A Breath Biopsy study with Cleveland Clinic proposing ketones and terpenes as possible biomarkers of chronic liver diseases.
- PUBLICATION: Volatile Biomarkers in Breath Associated With Liver Cirrhosis – Comparisons of Pre- and Post-liver Transplant Breath Samples.
- PAPER: Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes.
- POSTER: Breath Biopsy to Discover Novel Exogenous Volatile Organic Compound (EVOC®) Biomarkers for Chronic Liver Disease.
- DOWNLOAD: Breath Biopsy: The Complete Guide – Over 100 pages packed with everything you need to know about breath research, and the applications and technologies of Breath Biopsy.
- WATCH: Breath Biopsy Conference 2020 session: Breath Biomarkers for Liver Disease.
- PUBLICATION: Non-Invasive Distinction of Non-Alcoholic Fatty Liver Disease using Urinary Volatile Organic Compound Analysis: Early Results.
